ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0QNV Addex Therapeutics Ltd

3.02
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Addex Therapeutics Ltd 0QNV London Ordinary Share
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 3.02 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.02
more quote information »

Recent News

Date Time Source Heading
5/02/202410:07IHNWFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
4/29/202401:00UKREGAddex Provides Update on ADX71149 Phase 2 Epilepsy Study
4/19/202401:00UKREGAddex to Present at the Swiss Biotech Day 2024
4/18/202401:00UKREGAddex Therapeutics Reports Full Year 2023 Financial Results..
4/11/202401:00UKREGAddex Therapeutics to Release Full-Year 2023 Financial..
4/03/202401:00UKREGAddex and Perceptive Launch Neurosterix with $63 Million to..
3/14/202402:00UKREGAddex to Present at the Bio-Europe Spring 2024 Conference
1/31/202401:00UKREGAddex Enters into At-The-Market ADS Offering Agreement with..
1/09/202401:00GLOBEAddex to Present at the Swiss Equities Baader Conference
1/05/202401:30GLOBEAddex to Present at Biotech Showcase™ 2024
12/20/202301:00GLOBEAddex Shareholders Approve All Resolutions at Extraordinary..
12/14/202301:00GLOBEAddex Creates Treasury Shares
11/29/202301:00GLOBEAddex Reports Q3 2023 Financial Results and Provides..
11/28/202301:00GLOBEAddex Convenes Extraordinary General Meeting
11/23/202301:00GLOBEAddex Therapeutics to Release Third Quarter 2023 Financial..
11/14/202301:00GLOBEAddex ADX71149 Epilepsy Phase 2 Study Completes Recruitment..
11/08/202301:00GLOBEAddex Regains Nasdaq Listing Compliance
11/02/202302:00GLOBEAddex Announces Participation in the Bio-Europe 2023..
10/20/202301:00GLOBEAddex Completes ADS Ratio Change
10/06/202316:00GLOBEAddex Announces Plan to Implement ADS Ratio Change
9/20/202301:00GLOBEAddex mGlu2 NAM Cognition Program Receives €4 Million Grant
9/06/202301:00GLOBEAddex Announces Participation in the H.C. Wainwright 25th..
9/05/202301:00GLOBEAddex ADX71149 Phase 2 Epilepsy Study Expected to Readout..
9/04/202301:00GLOBEAddex’s Dipraglurant Development in Post-Stroke Recovery..
8/10/202301:00GLOBEAddex Reports 2023 Half Year and Second Quarter Financial..
8/04/202301:00GLOBEAddex Therapeutics to Release Half-Year 2023 Financial..
8/03/202301:00GLOBEAddex GABAB Positive Allosteric Modulator Program to Receive..
7/24/202301:00GLOBEAddex mGlu2PAM Demonstrates Potential in Substance Use..
6/15/202301:00GLOBEAddex Increases Issued Share Capital to Create Treasury..
6/01/202301:00GLOBEAddex Shareholders Approve All Resolutions at Annual General..
5/18/202301:00GLOBEAddex Receives Nasdaq Notification Regarding Minimum Bid..
5/11/202301:00GLOBEAddex Reports Q1 2023 Financial Results and Provides..
5/10/202301:00GLOBEAddex Announces ADX71149 Phase 2 Epilepsy Clinical Study’s..
5/05/202301:00GLOBEAddex Convenes Annual General Meeting 2023
5/04/202301:00GLOBEAddex Therapeutics to Release Q1 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock